<p>Percentage growth inhibition and IC<sub>50</sub> of UA in different breast cancer cell lines. MCF-7 and MCF 10A cells were treated with either doses of 2.5, 5 and 10μM UA or Doxorubicin for 48 hours and cytotoxicity was assessed by SRB assay. Columns, average of triplicate readings of samples; error bars, ± S.D. <b>C.</b> Phase-contrast photomicrograph of MCF-7 and MCF 10A cells treated with either vehicle control or different doses of UA.</p
<p>(A) Paired human normal breast cell line Hs 578Bst and human breast carcinoma cell line Hs 578T. ...
Endocrine resistance is a major problem with anti-estrogen treatments and how to overcome resistance...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p>MCF-7 cells were exposed to increasing doses (100 nM, 250 nM, 500 nM, 1 µM and 5 µM) of anthracyc...
<p>A) MCF-7 and the derived MCF-7 Dox<sup>R</sup> cells were treated with 0 to 10 µM of doxorubicin ...
The purpose of the current investigation was to identify the dose-dependent effect of doxorubicin on...
<p>(A) MTT assay of MCF-7, MDA-MB-231, BT474 and SUM1315 cells treated by DRβ-H. (B, C) Colony forma...
Different methods were compared for the in vitro evaluation of the therapeutic effects of the antine...
<p>(A-C) Photomicrographs of (A) MDA-MB-231, (B) MDA-MB-231SCP2, and (C) MDA-MB-231BR. Scale bar, 10...
<p>Viability of MDA-MB-231 cells was assessed by MTT assay after treatment with doxorubicin for 24 h...
<p>A. The structures of B02, doxorubicin, etoposide, topotecan and cisplatin. B. Survival of MDA-MB-...
<p>Viability of 4T1 or FL4T1 cells was assessed by the MTT assay after treatment with: doxorubicin f...
<p>(<b>A</b>). SRL causes dose-dependent inhibition of human breast cancer MCF-7 and ZR-75 cell prol...
<p><sup><i>a</i></sup> The IC<sub><b>50</b></sub> values were determined by the MTT assay after 48 h...
<p>Cells were pre-treated with the indicated concentrations of 8MOP for 4 hr before UVA irradiation ...
<p>(A) Paired human normal breast cell line Hs 578Bst and human breast carcinoma cell line Hs 578T. ...
Endocrine resistance is a major problem with anti-estrogen treatments and how to overcome resistance...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p>MCF-7 cells were exposed to increasing doses (100 nM, 250 nM, 500 nM, 1 µM and 5 µM) of anthracyc...
<p>A) MCF-7 and the derived MCF-7 Dox<sup>R</sup> cells were treated with 0 to 10 µM of doxorubicin ...
The purpose of the current investigation was to identify the dose-dependent effect of doxorubicin on...
<p>(A) MTT assay of MCF-7, MDA-MB-231, BT474 and SUM1315 cells treated by DRβ-H. (B, C) Colony forma...
Different methods were compared for the in vitro evaluation of the therapeutic effects of the antine...
<p>(A-C) Photomicrographs of (A) MDA-MB-231, (B) MDA-MB-231SCP2, and (C) MDA-MB-231BR. Scale bar, 10...
<p>Viability of MDA-MB-231 cells was assessed by MTT assay after treatment with doxorubicin for 24 h...
<p>A. The structures of B02, doxorubicin, etoposide, topotecan and cisplatin. B. Survival of MDA-MB-...
<p>Viability of 4T1 or FL4T1 cells was assessed by the MTT assay after treatment with: doxorubicin f...
<p>(<b>A</b>). SRL causes dose-dependent inhibition of human breast cancer MCF-7 and ZR-75 cell prol...
<p><sup><i>a</i></sup> The IC<sub><b>50</b></sub> values were determined by the MTT assay after 48 h...
<p>Cells were pre-treated with the indicated concentrations of 8MOP for 4 hr before UVA irradiation ...
<p>(A) Paired human normal breast cell line Hs 578Bst and human breast carcinoma cell line Hs 578T. ...
Endocrine resistance is a major problem with anti-estrogen treatments and how to overcome resistance...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...